Carlos Singer

10.1k total citations
134 papers, 3.8k citations indexed

About

Carlos Singer is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Carlos Singer has authored 134 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Neurology, 22 papers in Cellular and Molecular Neuroscience and 18 papers in Psychiatry and Mental health. Recurrent topics in Carlos Singer's work include Parkinson's Disease Mechanisms and Treatments (76 papers), Neurological disorders and treatments (61 papers) and Botulinum Toxin and Related Neurological Disorders (36 papers). Carlos Singer is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (76 papers), Neurological disorders and treatments (61 papers) and Botulinum Toxin and Related Neurological Disorders (36 papers). Carlos Singer collaborates with scholars based in United States, Spain and Argentina. Carlos Singer's co-authors include Spiridon Papapetropoulos, William J. Weiner, Juan Sanchez‐Ramos, Spyridon Papapetropoulos, Jeffery M. Vance, Henry Moore, Jason Margolesky, Stewart A. Factor, Liyong Wang and Alexandra Guevara and has published in prestigious journals such as PLoS ONE, Neurology and Medicine & Science in Sports & Exercise.

In The Last Decade

Carlos Singer

128 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Singer United States 32 2.8k 1.1k 409 400 391 134 3.8k
Roongroj Bhidayasiri Thailand 33 3.0k 1.1× 874 0.8× 550 1.3× 334 0.8× 271 0.7× 222 4.0k
Francisco Cardoso Brazil 37 3.3k 1.2× 1.6k 1.4× 583 1.4× 393 1.0× 514 1.3× 217 5.0k
Paolo Martinelli Italy 33 2.4k 0.9× 928 0.9× 369 0.9× 342 0.9× 532 1.4× 118 3.6k
Ruth Djaldetti Israel 36 3.0k 1.1× 1.2k 1.1× 384 0.9× 598 1.5× 760 1.9× 129 4.7k
Sun Ju Chung South Korea 34 2.9k 1.1× 872 0.8× 396 1.0× 516 1.3× 465 1.2× 211 4.3k
Oksana Suchowersky Canada 40 3.1k 1.1× 1.5k 1.3× 593 1.4× 299 0.7× 788 2.0× 124 4.9k
Michele Tagliati United States 41 3.3k 1.2× 1.6k 1.5× 320 0.8× 403 1.0× 439 1.1× 111 4.5k
Peter Kempster Australia 27 3.0k 1.1× 772 0.7× 398 1.0× 440 1.1× 149 0.4× 87 3.8k
Jean Hubble United States 31 2.9k 1.0× 1.5k 1.4× 317 0.8× 256 0.6× 288 0.7× 58 3.6k
Carsten Buhmann Germany 32 2.2k 0.8× 889 0.8× 316 0.8× 512 1.3× 502 1.3× 146 3.7k

Countries citing papers authored by Carlos Singer

Since Specialization
Citations

This map shows the geographic impact of Carlos Singer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Singer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Singer more than expected).

Fields of papers citing papers by Carlos Singer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Singer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Singer. The network helps show where Carlos Singer may publish in the future.

Co-authorship network of co-authors of Carlos Singer

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Singer. A scholar is included among the top collaborators of Carlos Singer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Singer. Carlos Singer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shih, Ludy C., Michael Stevenson, Steven Bellows, et al.. (2024). Validation of a New Patient-Reported Outcome Measure of the Functional Impact of Essential Tremor on Activities of Daily Living. Tremor and Other Hyperkinetic Movements. 14. 26–26. 1 indexed citations
2.
Margolesky, Jason, Corneliu Luca, Henry Moore, et al.. (2023). Blepharoclonus in Parkinsonism. Neurology Clinical Practice. 14(1). e200240–e200240. 1 indexed citations
3.
Cubo, Esther, Sheng Luo, Pablo Martínez‐Martín, et al.. (2023). Expanded and Independent Spanish Validation of the MDS‐Non Motor Rating Scale. Movement Disorders Clinical Practice. 10(4). 586–595. 1 indexed citations
4.
Singer, Carlos & Stephen G. Reich. (2019). Parkinson Disease. Clinics in Geriatric Medicine. 36(1). i–i. 1 indexed citations
5.
Margolesky, Jason, Corneliu Luca, Carlos Singer, et al.. (2019). Revisiting eligibility for deep brain stimulation: Do preoperative mood symptoms predict outcomes in Parkinson's disease patients?. Parkinsonism & Related Disorders. 63. 131–136. 6 indexed citations
7.
Luca, Corneliu, et al.. (2017). Dalfampridine in Parkinson's disease related gait dysfunction: A randomized double blind trial. Journal of the Neurological Sciences. 379. 7–11. 6 indexed citations
8.
Singer, Carlos, et al.. (2016). Initial Deep Brain Stimulation Programming Optimization Using the Personal KinetiGraph(PKG) Movement Recording System (P3.364). Neurology. 86(16_supplement). 2 indexed citations
9.
Simon, David K., Cai Wu, Barbara C. Tilley, et al.. (2015). Caffeine and Progression of Parkinson Disease. Clinical Neuropharmacology. 38(5). 163–169. 20 indexed citations
10.
Moore, Henry, et al.. (2014). A Case of Klinefelter Syndrome Associated with Parkinsonism (P5.255). Neurology. 82(10_supplement).
11.
Vance, Jeffery M., Syed F. Ali, Walter G. Bradley, Carlos Singer, & Donato A. Di Monte. (2010). Gene–environment interactions in Parkinson's disease and other forms of parkinsonism. NeuroToxicology. 31(5). 598–602. 53 indexed citations
12.
Edwards, Todd L., William K. Scott, Amber Burt, et al.. (2010). Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease. Annals of Human Genetics. 74(2). 97–109. 370 indexed citations
13.
Papapetropoulos, Spiridon, Bruno V. Gallo, Alexandra Guevara, et al.. (2009). Objective tremor registration during DBS surgery for Essential Tremor. Clinical Neurology and Neurosurgery. 111(4). 376–379. 11 indexed citations
14.
Simon, David K., Christopher J. Swearingen, Robert A. Hauser, et al.. (2008). Caffeine and Progression of Parkinson Disease. Clinical Neuropharmacology. 31(4). 189–196. 32 indexed citations
15.
Papapetropoulos, Spiridon, Jennifer Friedman, Craig Blackstone, et al.. (2007). A progressive, fatal dystonia‐Parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy. Movement Disorders. 22(11). 1664–1666. 5 indexed citations
16.
Papapetropoulos, Spiridon & Carlos Singer. (2007). Botulinum Toxin in Movement Disorders. Seminars in Neurology. 27(2). 183–194. 15 indexed citations
17.
Papapetropoulos, Spiridon & Carlos Singer. (2006). Painless legs moving toes in a patient with Wilson's disease. Movement Disorders. 21(4). 579–580. 24 indexed citations
18.
Zamir, Doron, et al.. (1998). Elevated Ovarian Cancer Marker(CA-125) in Cirrhotic Patients With Intractable Ascites. Journal of Clinical Gastroenterology. 27(2). 154–155. 3 indexed citations
19.
Kurth, Matthias, Charles H. Adler, Melissa St Hilaire, et al.. (1997). Tolcapone Improves Motor Function and Reduces Levodopa Requirement in Patients with Parkinson's Disease Experiencing Motor Fluctuations. Neurology. 48(1). 81–87. 151 indexed citations
20.
Singer, Carlos & William J. Weiner. (1994). Sexual dysfunction : a neuro-medical approach. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026